Annual flu vaccines demonstrate effectiveness ranging from 10% to 60%, hinging on the match between circulating strains and the vaccine composition. This variability outperforms #7 Vaccine Ingredient Transparency in generating public skepticism, yet even a 20% effective vaccine prevents 40% of hospitalizations in older adults. For example, during the 2019-2020 season in the U.S., vaccination prevented an estimated 105,000 hospitalizations. Cheaper than the typical rival in healthcare costs, each dose averages under $20, reducing severe outcomes by up to 60% when matched well. Unlike the fixed protection of the #6 HPV vaccine, flu vaccines require annual updates because the virus mutates rapidly, with two subtypes circulating each season—a challenge that experts say still justifies widespread immunization to protect vulnerable populations.
Comments on "Flu Vaccine Effectiveness Variability"
Create a free account or sign in to join the discussion.
Sign in to join the conversation